[1]
2026. Nasway Use as an Independent Adverse Prognostic Factor in Oral Squamous Cell Carcinoma: A Retrospective Cohort Study from Uzbekistan. Journal of Carcinogenesis. 25, 1 (Oct. 2026), 671–679. DOI:https://doi.org/10.66838/J.Carcinog.25.1.671-679.